JPWO2021085535A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021085535A5
JPWO2021085535A5 JP2021553684A JP2021553684A JPWO2021085535A5 JP WO2021085535 A5 JPWO2021085535 A5 JP WO2021085535A5 JP 2021553684 A JP2021553684 A JP 2021553684A JP 2021553684 A JP2021553684 A JP 2021553684A JP WO2021085535 A5 JPWO2021085535 A5 JP WO2021085535A5
Authority
JP
Japan
Prior art keywords
formula
represented
compound
hydrogen atom
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021553684A
Other languages
Japanese (ja)
Other versions
JPWO2021085535A1 (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/040648 external-priority patent/WO2021085535A1/en
Publication of JPWO2021085535A1 publication Critical patent/JPWO2021085535A1/ja
Publication of JPWO2021085535A5 publication Critical patent/JPWO2021085535A5/ja
Pending legal-status Critical Current

Links

Claims (6)

下記一般式（２）：
Figure 2021085535000001
 （式中、ｐ１は０、１又は２である。）
で表される化合物と、下記一般式（３）：
Figure 2021085535000002
 （式中、Ｒ１、Ｒ２及びＲ３は、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、Ｒ１、Ｒ２及びＲ３のうちの２個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよく；Ｘはハロゲン原子である。）
で表される化合物と、を反応させることにより、下記一般式（１）：
Figure 2021085535000003
 （式中、Ｚ１は、水素原子又は一般式「－ＳｉＲ１Ｒ２Ｒ３」で表される基であり、（２ｐ１＋６）個のＺ１は互いに同一でも異なっていてもよく、ただし、１個又は２個以上のＺ１は、前記一般式「－ＳｉＲ１Ｒ２Ｒ３」で表される基であり；ｐ１、Ｒ１、Ｒ２及びＲ３は、上記と同じである。）
で表される化合物を得る、化合物の製造方法であって、
一般式（２）の化合物として水和水を含まない結晶を用いる、化合物の製造方法。The following general formula (2):
Figure 2021085535000001
 (In the formula, p 1 is 0, 1 or 2.)
and a compound represented by the following general formula (3):
Figure 2021085535000002
 (wherein R 1 , R 2 and R 3 are each independently a hydrogen atom, or an optionally substituted alkyl group or aryl group, and R 1 , R 2 and R 3 When two or more are the above alkyl groups or aryl groups, these groups may be bonded together to form a ring; X is a halogen atom.)
By reacting a compound represented by the following general formula (1):
Figure 2021085535000003
 (In the formula, Z 1 is a hydrogen atom or a group represented by the general formula “—SiR 1 R 2 R 3 ”, and (2p 1 +6) Z 1s may be the same or different, provided that , one or more Z 1 is a group represented by the general formula “—SiR 1 R 2 R 3 ”; p 1 , R 1 , R 2 and R 3 are the same as above. .)
A method for producing a compound to obtain a compound represented by
A method for producing a compound using a crystal containing no water of hydration as the compound of general formula (2). 下記一般式（１０）：
Figure 2021085535000004
 （式中、ｐ１は０、１又は２であり；Ｚ１０は、水素原子又は一般式「－ＳｉＲ１０Ｒ２０Ｒ３０」で表される基であり、（２ｐ１＋６）個のＺ１０は互いに同一でも異なっていてもよく、ただし、１個又は２個以上のＺ１０は、前記一般式「－ＳｉＲ１０Ｒ２０Ｒ３０」で表される基であり；Ｒ１０、Ｒ２０及びＲ３０は、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、Ｒ１０、Ｒ２０及びＲ３０のうちの２個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。）
で表される化合物（ただし、ｐ１が１であり、８個のＺ１０がすべて式「－Ｓｉ（ＣＨ３）３」、式「－Ｓｉ（ＣＨ３）２Ｈ」、式「－Ｓｉ（（４－ＣＨ３）Ｃ６Ｈ４）（ＣＨ３）２」、式「－Ｓｉ（（４－ＣＢｒ３）Ｃ６Ｈ４）（ＣＨ３）２」、式「－Ｓｉ（（４－ＣＯＯＨ）Ｃ６Ｈ４）（ＣＨ３）２」、式「－Ｓｉ（ＣＨ３）２（ＯＳｉ（ＣＨ３）３）」、式「－Ｓｉ（ＣＨ３）２（ＣＨ＝ＣＨ２）」、式「－Ｓｉ（ＣＨ＝ＣＨ２）３」、式「－Ｓｉ（ＣＨ３）２ＣＨ２Ｃｌ」、又は式「－Ｓｉ（ＣＨ３）２（ＯＳｉ（ＣＨ３）３）」で表される基である化合物と、ｐ１が１であり、７個のＺ１０が式「－Ｓｉ（ＣＨ３）３」で表される基であり、１個のＺ１０が水素原子である化合物と、ｐ１が１であり、６個のＺ１０が式「－Ｓｉ（ＣＨ３）３」で表される基であり、２個のＺ１０が水素原子である化合物と、ｐ１が１であり、５個のＺ１０が式「－Ｓｉ（ＣＨ３）３」で表される基であり、３個のＺ１０が水素原子である化合物と、を除く）。The following general formula (10):
Figure 2021085535000004
 (In the formula, p 1 is 0, 1 or 2; Z 10 is a hydrogen atom or a group represented by the general formula “—SiR 10 R 20 R 30 ”, and (2p 1 +6) Z 10 may be the same or different, provided that one or more Z 10 is a group represented by the general formula “—SiR 10 R 20 R 30 ”; R 10 , R 20 and R 30 each independently represents a hydrogen atom, an optionally substituted alkyl group or an aryl group, and two or more of R 10 , R 20 and R 30 are the alkyl group or aryl group; In some cases, these groups may be bonded together to form a ring.)
(where p 1 is 1 and all eight Z 10 are of the formula "-Si( CH3 ) 3 ", the formula "-Si( CH3 ) 2H ", the formula "-Si( (4-CH 3 )C 6 H 4 )(CH 3 ) 2 ”, formula “-Si((4-CBr 3 )C 6 H 4 )(CH 3 ) 2 ”, formula “-Si((4-COOH )C 6 H 4 )(CH 3 ) 2 ”, formula “—Si(CH 3 ) 2 (OSi(CH 3 ) 3 )”, formula “—Si(CH 3 ) 2 (CH═CH 2 )”, formula A group represented by the formula "-Si(CH=CH 2 ) 3 ", the formula "-Si(CH 3 ) 2 CH 2 Cl", or the formula "-Si(CH 3 ) 2 (OSi(CH 3 ) 3 )" a compound in which p 1 is 1, seven Z 10 are groups represented by the formula “—Si(CH 3 ) 3 ”, and one Z 10 is a hydrogen atom, and p a compound in which 1 is 1, 6 Z 10 are groups represented by the formula “—Si(CH 3 ) 3 ”, and 2 Z 10 are hydrogen atoms, and p 1 is 1; excluding compounds in which 5 Z 10 are groups represented by the formula “—Si(CH 3 ) 3 ” and 3 Z 10 are hydrogen atoms). 前記Ｒ１０、Ｒ２０及びＲ３０が、それぞれ独立に、水素原子、炭素数１～２０のアルキル基又は炭素数６～２０のアリール基である、請求項２に記載の化合物。3. The compound according to claim 2, wherein said R 10 , R 20 and R 30 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms or an aryl group having 6 to 20 carbon atoms. 前記Ｒ１０、Ｒ２０及びＲ３０が、ぞれぞれ独立に、水素原子、炭素数１～６のアルキル基又は炭素数６～１２のアリール基である、請求項２又は３に記載の化合物。4. The compound according to claim 2 or 3, wherein said R 10 , R 20 and R 30 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an aryl group having 6 to 12 carbon atoms. . 下記一般式（１０２１）：
Figure 2021085535000005
 （式中、Ｚ１１は、水素原子又は一般式「－ＳｉＲ１１Ｒ２１Ｒ３１」で表される基であり、８個のＺ１１は互いに同一でも異なっていてもよく、ただし、１個又は２個以上のＺ１１は、前記一般式「－ＳｉＲ１１Ｒ２１Ｒ３１」で表される基であり；Ｒ１１、Ｒ２１及びＲ３１は、それぞれ独立に、水素原子、炭素数１～６のアルキル基又は炭素数６～１２のアリール基であり、Ｒ１１、Ｒ２１及びＲ３１のうちの２個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。）
で表される化合物（ただし、８個のＺ１１がすべて式「－Ｓｉ（ＣＨ３）３」、式「－Ｓｉ（ＣＨ３）２Ｈ」、式「－Ｓｉ（（４－ＣＨ３）Ｃ６Ｈ４）（ＣＨ３）２」、式「－Ｓｉ（（４－ＣＢｒ３）Ｃ６Ｈ４）（ＣＨ３）２」、式「－Ｓｉ（（４－ＣＯＯＨ）Ｃ６Ｈ４）（ＣＨ３）２」、式「－Ｓｉ（ＣＨ３）２（ＯＳｉ（ＣＨ３）３）」、式「－Ｓｉ（ＣＨ３）２（ＣＨ＝ＣＨ２）」、式「－Ｓｉ（ＣＨ＝ＣＨ２）３」、式「－Ｓｉ（ＣＨ３）２ＣＨ２Ｃｌ」、又は式「－Ｓｉ（ＣＨ３）２（ＯＳｉ（ＣＨ３）３）」で表される基である化合物と、７個のＺ１１が式「－Ｓｉ（ＣＨ３）３」で表される基であり、１個のＺ１１が水素原子である化合物と、６個のＺ１１が式「－Ｓｉ（ＣＨ３）３」で表される基であり、２個のＺ１１が水素原子である化合物と、５個のＺ１１が式「－Ｓｉ（ＣＨ３）３」で表される基であり、３個のＺ１１が水素原子である化合物と、を除く）。The following general formula (1021):
Figure 2021085535000005
 (In the formula, Z 11 is a hydrogen atom or a group represented by the general formula “—SiR 11 R 21 R 31 ”, and the eight Z 11 may be the same or different, provided that one or Two or more Z 11 are groups represented by the general formula “—SiR 11 R 21 R 31 ”; R 11 , R 21 and R 31 each independently represent a hydrogen atom having 1 to 6 carbon atoms or an aryl group having 6 to 12 carbon atoms, and two or more of R 11 , R 21 and R 31 are the alkyl group or aryl group, these groups are bonded to each other to form a ring may be formed).
(provided that all eight Z 11 are of the formula “—Si(CH 3 ) 3 ”, the formula “—Si(CH 3 ) 2 H”, the formula “—Si((4-CH 3 )C 6 H 4 )(CH 3 ) 2 ”, formula “—Si((4-CBr 3 )C 6 H 4 )(CH 3 ) 2 ”, formula “—Si((4-COOH)C 6 H 4 )( CH 3 ) 2 ”, formula “-Si(CH 3 ) 2 (OSi(CH 3 ) 3 )”, formula “-Si(CH 3 ) 2 (CH=CH 2 )”, formula “-Si(CH=CH 2 ) 3 ”, a compound represented by the formula “—Si(CH 3 ) 2 CH 2 Cl”, or a group represented by the formula “—Si(CH 3 ) 2 (OSi(CH 3 ) 3 )”; wherein Z 11 is a group represented by the formula “—Si(CH 3 ) 3 ”, one Z 11 is a hydrogen atom, and a compound in which six Z 11 are represented by the formula “—Si(CH 3 ) 3 ", two Z 11 are hydrogen atoms, and five Z 11 are groups represented by the formula "-Si(CH 3 ) 3 ", three Z except for compounds in which 11 is a hydrogen atom). 一般式（２）の化合物として水以外の溶媒成分の分子を含む結晶を用いる、請求項１に記載の化合物の製造方法。 2. The method for producing a compound according to claim 1, wherein a crystal containing molecules of a solvent component other than water is used as the compound of general formula (2).
JP2021553684A 2019-10-31 2020-10-29 Pending JPWO2021085535A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019199348 2019-10-31
PCT/JP2020/040648 WO2021085535A1 (en) 2019-10-31 2020-10-29 Compound and production method therefor

Publications (2)

Publication Number Publication Date
JPWO2021085535A1 JPWO2021085535A1 (en) 2021-05-06
JPWO2021085535A5 true JPWO2021085535A5 (en) 2022-08-12

Family

ID=75716345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553684A Pending JPWO2021085535A1 (en) 2019-10-31 2020-10-29

Country Status (2)

Country Link
JP (1) JPWO2021085535A1 (en)
WO (1) WO2021085535A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348705A3 (en) * 1988-06-29 1991-02-27 Akademie der Wissenschaften der DDR Organophilic double-ring silicilic-acid derivatives with cage structures, process for their preparation and their use
JP4645803B2 (en) * 2004-10-05 2011-03-09 信越化学工業株式会社 Monofunctional monomer having cage oligosiloxane structure and method for producing the same
TW200848935A (en) * 2007-02-08 2008-12-16 Fujifilm Electronic Materials Photosensitive compositions employing silicon-containing additives

Similar Documents

Publication Publication Date Title
JP2009523146A5 (en)
JP2010525122A5 (en)
JP2019104748A5 (en)
JP2018127459A5 (en)
JP2006502283A5 (en)
JP2010510976A5 (en)
JP2020523378A5 (en)
ATE518972T1 (en) SILANE COMPOSITION, METHOD FOR PRODUCING A SILICON FILM AND A SOLAR CELL
JP2007523139A5 (en)
JP2012149045A5 (en) Benzo [b] naphtho [1,2-d] furan compounds
JP2009511649A5 (en)
JP2009536221A5 (en)
JP2010524927A5 (en) Compound 2-Hydroxy-3- [5- (morpholin-4-ylmethyl) pyridin-2-yl] 1H-indole-5-carbonitrile
JP2007538042A5 (en)
JP2004505965A5 (en)
JP2009514955A5 (en)
JP2011526896A5 (en)
JP2006523241A5 (en)
RU2006121438A (en) METHOD FOR OBTAINING BISPHOSPHOLAN LIGANDS
JP2010519375A5 (en)
DE602004009943D1 (en) 9,10-ALPHA, ALPHA-OH-TAXANANALOGA AND METHOD FOR THE PRODUCTION THEREOF
JP2022116171A5 (en)
JPWO2021085535A5 (en)
JP2006316032A5 (en)
JPWO2021030554A5 (en)